BioIVT has acquired PrecisionMed, a supplier of human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics.
Based in Carlsbad, CA, US, PrecisionMed has been collecting biospecimens for neurology and oncology research for more than 27 years, and reportedly has the largest private, global repository of longitudinally collected human CSF for scientific research.
Its collection contains both normal and diseased CSF samples together with other matched biofluids, such as plasma, sera, and whole blood.
“We are thrilled to announce BioIVT’s acquisition of PrecisionMed. Our vision is to lead the biospecimen industry through expertise and innovation and our acquisition of PrecisionMed pushes us even closer to this goal,” said BioIVT Chief Executive Officer Richard Haigh.
“The vision at PrecisionMed has always been centered around positively impacting patients’ lives through fueling innovation and scientific discovery. This partnership magnifies our collective ability to reach the research community and impact patient lives,” added PrecisionMed CEO Eric Leach.
